← Back to home

EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN)

Clinical trials for EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN) explained in plain language.

Never miss a new study

Get alerted when new EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN) trials appear

Sign up with your email to follow new studies for EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Researchers track High-Risk pregnancies to understand severe newborn condition

Knowledge-focused Completed

This study aimed to better understand the health journey of pregnant women and their babies who are at high risk for a severe blood disease in newborns. Researchers observed the standard medical care and outcomes for 17 participants without testing a new treatment. The goal was t…

Matched conditions: EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN)

Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:38 UTC

EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN)

Get alerted when new EARLY ONSET SEVERE HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN (EOS-HDFN) trials appear

Researchers track High-Risk pregnancies to understand severe newborn condition